Cargando…

GSK3β is a new therapeutic target for myotonic dystrophy type 1

Myotonic dystrophy type 1 (DM1), an incurable, neuromuscular disease, is caused by the expansion of CTG repeats within the 3′ UTR of DMPK on chromosome 19q. In DM1 patients, mutant DMPK transcripts deregulate RNA metabolism by altering CUG RNA-binding proteins. Several approaches have been proposed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Christina, Jones, Karlie, Timchenko, Nikolai A, Timchenko, Lubov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Addendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927489/ https://www.ncbi.nlm.nih.gov/pubmed/25003008 http://dx.doi.org/10.4161/rdis.26555

Ejemplares similares

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy
por: Lutz, Maggie, et al.
Publicado: (2023)

Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1
por: Timchenko, Lubov
Publicado: (2019)

Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
por: Timchenko, Lubov
Publicado: (2022)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022)

Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
por: Schoser, Benedikt, et al.
Publicado: (2010)

GSK3β and aging liver
por: Jin, Jingling, et al.
Publicado: (2009)

Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicing
por: Hernández-Hernández, Oscar, et al.
Publicado: (2013)

Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I
por: Bondy-Chorney, Emma, et al.
Publicado: (2016)

Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy
por: Whitehead, Nicholas P., et al.
Publicado: (2016)

Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy
por: Pantoja, Mario, et al.
Publicado: (2013)

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial
por: Kurkiewicz, Adam, et al.
Publicado: (2020)

Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
por: Stadler, Guido, et al.
Publicado: (2013)

Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
por: Gulati, Ruhi, et al.
Publicado: (2022)

The immune system in Duchenne muscular dystrophy: Friend or foe
por: Villalta, S Armando, et al.
Publicado: (2015)

Addendum: Liu, B. et al. The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer. Int. J. Mol. Sci. 2018, 19, 1870
por: Liu, Bin, et al.
Publicado: (2019)

Smaug/SAMD4A Restores Translational Activity of CUGBP1 and Suppresses CUG-Induced Myopathy
por: de Haro, Maria, et al.
Publicado: (2013)

Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies
por: Giordani, L, et al.
Publicado: (2014)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Help for Sick Kids: New Insights Into Hepatoblastoma
por: Timchenko, Nikolai A.
Publicado: (2021)

Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation
por: Kinghorn, Kerri J., et al.
Publicado: (2016)

Cell-type specific functions of epidermal growth factor receptor are involved in development of hepatocellular carcinoma
por: Timchenko, Nikolai A
Publicado: (2015)

Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease
por: Cast, Ashley, et al.
Publicado: (2019)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)

Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome
por: Rannals, Matthew D., et al.
Publicado: (2016)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
por: Liu, Jie, et al.
Publicado: (2021)

Addendum: TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging
por: Lyu, Guoliang, et al.
Publicado: (2018)

Yeast genetic screen reveals novel therapeutic strategy for ALS
por: Figley, Matthew D., et al.
Publicado: (2013)

Retraction: Hsp90β is involved in the development of high salt-diet-induced nephropathy via interaction with various signalling proteins
por: Yan, Shi-hai, et al.
Publicado: (2021)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Inflammatory bactericidal lectin RegIIIβ: Friend or foe for the host?
por: Miki, Tsuyoshi, et al.
Publicado: (2017)

Editorial Expression of Concern: Glial β-Oxidation regulates Drosophila Energy Metabolism
por: Schulz, Joachim G., et al.
Publicado: (2020)

ADDENDUM: A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals
por: Moriguchi, Hisashi, et al.
Publicado: (2012)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mahadevan, Mani S., et al.
Publicado: (2021)

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
por: López Castel, Arturo, et al.
Publicado: (2019)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Myotonic dystrophy: new clues from flies
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0glk4p9e579nggmtji403khi1l